Silva J J, Tsang R W, Panzarella T, Levin W, Wells W
Department of Radiation Oncology, Princess Margaret Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Int J Radiat Oncol Biol Phys. 2000 May 1;47(2):451-9. doi: 10.1016/s0360-3016(00)00410-7.
To assess the treatment outcome, late toxicity, and prognostic factors for radiotherapy (RT) of carcinoma of the pinna.
The charts of 313 patients treated between 01/82 and 12/93 were retrospectively reviewed. There were 334 lesions treated: 201 basal cell carcinoma (BCC), 122 squamous cell carcinoma (SCC), and 11 basosquamous carcinoma. RT was most commonly given by orthovoltage X-rays (278 lesions) or electrons (39 lesions). The most frequently used dose prescriptions were 35 Gy in 5 fractions (123 treatments with median field size = 4.9 cm(2)), 42. 5-45 Gy in 10 fractions (67 treatments with median field size = 10.5 cm(2)), and 50-65 Gy in 20-30 fractions (42 treatments with median field size = 81 cm(2)).2 cm. RESUL TS: The actuarial 2- and 5-year local control rates were 86.6% and 79.2 %. Multivariate analysis revealed two factors to be statistically signi ficant for increased local failure: tumor size > 2 cm (hazard ratio [HR] = 2.66, 95% confidence interval [CI] = 1.16-6.08), and a low biological effective dose (BED) (for each decrease of 5 BED units, HR = 1.76, 95% CI = 1.07-2.88). The 5-year actuarial rate of significant Grade 4 late toxicity was 7.3%. Factors statistically significant for this endpoint on univariate analysis were tumor size (p = 0.035), T-stage (p = 0.02), field size (p = 0.05), fraction size (p = 0.003), and BED (p = 0.05).
RT is an eff ctive treatment option for epithelial skin cancer of the pinna. Large t umor size and low BED were independently statistically significantly ass ociated with increased local failure. Dose-fractionation schedules usin g fraction sizes < 4 Gy may reduce the risk of necrosis and ulceration, particularly for field sizes > 5 cm2.
评估耳廓癌放射治疗(RT)的治疗效果、晚期毒性及预后因素。
回顾性分析1982年1月至1993年12月期间接受治疗的313例患者的病历。共治疗334个病灶:201例基底细胞癌(BCC)、122例鳞状细胞癌(SCC)和11例基底鳞状细胞癌。RT最常用的是正交电压X线(278个病灶)或电子线(39个病灶)。最常用的剂量处方为5次分割给予35 Gy(123次治疗,中位野大小=4.9 cm²)、10次分割给予42.5 - 45 Gy(67次治疗,中位野大小=10.5 cm²)以及20 - 30次分割给予50 - 65 Gy(42次治疗,中位野大小=81 cm²)。结果:2年和5年的精算局部控制率分别为86.6%和79.2%。多因素分析显示,肿瘤大小>2 cm(风险比[HR]=2.66,95%置信区间[CI]=1.16 - 6.08)和低生物等效剂量(BED)(每降低5个BED单位,HR = 1.76,95% CI = 1.07 - 2.88)这两个因素与局部失败增加在统计学上具有显著意义。5年精算严重4级晚期毒性发生率为7.3%。单因素分析中,对此终点具有统计学显著意义的因素为肿瘤大小(p = 0.035)、T分期(p = 0.02)、野大小(p = 0.05)、分割剂量(p = 0.003)和BED(p = 0.05)。
RT是耳廓上皮性皮肤癌的一种有效治疗选择。肿瘤体积大及BED低与局部失败增加独立相关,且在统计学上具有显著意义。使用分割剂量<4 Gy的剂量分割方案可能会降低坏死和溃疡的风险,特别是对于野大小>5 cm²的情况。